Ignite Creation Date:
2025-12-24 @ 1:27 PM
Ignite Modification Date:
2025-12-29 @ 3:13 PM
Study NCT ID:
NCT05388695
Status:
RECRUITING
Last Update Posted:
2025-06-18
First Post:
2022-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-19
First Submit QC Date:
None
Study First Post Date:
2022-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-16
Last Update Post Date:
2025-06-18
Last Update Post Date Type:
ACTUAL